Tuberculosis screening of travelers to higher-incidence countries
A cost-effectiveness analysis
Bibliographic Data
| ID | 15362109 |
|---|---|
| Authors | Michael Tan (0000-0003-1841-6226, Montreal Heart Institute, corresponding author), Dick Menzies (0000-0003-1601-4514, Montreal Heart Institute), Kevin Schwartzman (0000-0002-3354-1159, McGill University) |
| Year | 2008 |
| Volume | 8 |
| Issue | 1 |
| Pages | 201-201 |
| Publication date | 2008-06-05 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | BMC Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1471-2458 • E-ISSN: 1471-2458 |
| Publisher | BioMed Central (PUBLISHER • GB) |
| DOI | 10.1186/1471-2458-8-201 |
| PMID | 18534007 |
| PMCID | PMC2443799 |
| OpenAlex | W1982791156 |
| Language | EN |
| Citations received | 1 |
| References cited | 32 |
A single post-trip tuberculin skin test was the most cost-effective strategy considered, for travelers from the United States or Canada. The analysis did not evaluate the use of interferon-gamma release assays, which would be most relevant for travelers who received BCG vaccination after infancy, as in many European countries. Screening decisions should reflect duration of travel, tuberculosis incidence, and commitment to treat latent infection
Biostatistics · Cost effectiveness · Environmental health · Incidence (geometry · Psychological intervention · Public health · Tuberculin · Tuberculosis · Demography · Medicine · Pneumocystis jirovecii pneumonia detection and treatment · Travel-related health issues · Tuberculosis Research and Epidemiology · Epidemiology · Internal Medicine · Pediatrics
| Citations per year | 0.2 |
|---|---|
| Citation span | 2021 - 2021 (1) |
| Highly cited | No |